SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A fair growth of 16.65% in the revenue at Rs. 16500.10 millions was reported in the March 2025 quarter as compared to Rs. 14145.20 millions during year-ago period.The company almost doubled its revenue to Rs. 2519.00 millions  from Rs. 1213.20 millions in the quarter ended March 2025.OP of the company witnessed a marginal growth to 4669.90 millions from 2952.00 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 16500.10 14145.20 16.65 52169.80 48123.90 8.41 52169.80 48123.90 8.41
Other Income 721.60 240.90 199.54 1004.70 474.20 111.87 1004.70 474.20 111.87
PBIDT 4669.90 2952.00 58.19 10448.00 7973.00 31.04 10448.00 7973.00 31.04
Interest 486.00 419.90 15.74 1822.00 1508.20 20.81 1822.00 1508.20 20.81
PBDT 4183.90 2532.10 65.23 8626.00 6464.80 33.43 8626.00 6464.80 33.43
Depreciation 881.90 889.00 -0.80 3587.90 3450.10 3.99 3587.90 3450.10 3.99
PBT 3302.00 1643.10 100.96 5038.10 3014.70 67.12 5038.10 3014.70 67.12
TAX 783.00 429.90 82.14 1234.20 777.70 58.70 1234.20 777.70 58.70
Deferred Tax -37.70 -29.50 27.80 -304.20 -101.70 199.12 -304.20 -101.70 199.12
PAT 2519.00 1213.20 107.63 3803.90 2237.00 70.04 3803.90 2237.00 70.04
Equity 1078.50 1077.90 0.06 1078.50 1077.90 0.06 1078.50 1077.90 0.06
PBIDTM(%) 28.30 20.87 35.62 20.03 16.57 20.88 20.03 16.57 20.88

Laurus Labs Share Price

1135.00 5.40 (0.48%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×